Mohammed A Latif

Title: Mohammed A Latif: Innovator in Pharmaceutical Compounds

Introduction

Mohammed A Latif is a notable inventor based in Slough, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target critical health issues. With a total of 6 patents to his name, Latif's work is recognized for its potential impact on various diseases.

Latest Patents

Latif's latest patents focus on pharmaceutical compounds, specifically fused pyrimidines of formula (I). These compounds, along with their pharmaceutically acceptable salts, exhibit activity as inhibitors of PI3K. This mechanism may be utilized to treat diseases and disorders associated with abnormal cell growth, function, or behavior linked to PI3 kinase. Such conditions include cancer, immune disorders, cardiovascular diseases, viral infections, inflammation, metabolism/endocrine disorders, and neurological disorders. The patents also describe processes for synthesizing these innovative compounds.

Career Highlights

Throughout his career, Mohammed A Latif has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with F. Hoffmann-La Roche AG and Piramed Limited. His experience in these organizations has contributed to his expertise in developing groundbreaking pharmaceutical solutions.

Collaborations

Latif has collaborated with esteemed colleagues in his field, including Stephen Joseph Shuttleworth and Adrian Folkes. These partnerships have likely enhanced his research and development efforts, leading to innovative advancements in pharmaceutical compounds.

Conclusion

In summary, Mohammed A Latif is a distinguished inventor whose work in pharmaceutical compounds has the potential to address significant health challenges. His contributions to the field are marked by a commitment to innovation and collaboration.